
November 20, 2017
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Safety Podcast: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric)
- La FDA evaluará el aumento en el riesgo de muerte por causas cardíacas y de muerte por cualquier causa con el medicamento para la gota febuxostat (Uloric)
- National Drug Code Directory (updated)
- Public Notifications:
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario